Filing Details
- Accession Number:
- 0001179110-15-007284
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-07 17:52:32
- Reporting Period:
- 2015-05-05
- Filing Date:
- 2015-05-07
- Accepted Time:
- 2015-05-07 17:52:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1456804 | G Michael Howley | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Vp, Global Sales & Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2015-05-05 | 15,000 | $0.00 | 90,583 | No | 4 | A | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 3,570 | $70.29 | 87,013 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 950 | $71.62 | 86,063 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 380 | $72.76 | 85,683 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 100 | $73.22 | 85,583 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-31 | 15,000 | $0.00 | 15,000 | $5.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-03-31 | 2019-05-28 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $5.23 | 2009-03-05 | 2019-03-05 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 30,000 | Direct |
| Common Stock | Stock Option (Right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 25,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-03-05 | 0 | 25,000 | Direct |
| 2020-06-03 | 0 | 30,000 | Direct |
| 2022-05-22 | 0 | 25,000 | Direct |
| 2023-05-14 | 0 | 25,000 | Direct |
| 2024-05-14 | 0 | 25,000 | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
- These options became exerciseable upon the achievement of a certain performance milestone.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 14, 2014. One third of these restricted stock units vested on May 5, 2015 (into an equal number of shares of common stock) upon the issuer's achievement of a certain performance milestone with the remaining vesting on the first and second anniversary of the date of the grant.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan, including for payment of withholding tax liability associated with the vesting of performance-based awards of restricted stock units.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.0100 and $70.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.0100 and $72.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.1600 and $73.1500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
